Firefly Neuroscience, Inc. (AIFF) stock
AIFFNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/3046% below fair value
$0.94−0.03 (-2.97%)
Close on Nov 13, 2026Market cap $14.67MP/E –Yield –
Firefly Neuroscience r&d expenses
Research and development expenses are spending on new products and technology.
Firefly Neuroscience's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.79M, up 22.2% year over year. For fiscal 2025 it was $1.48M, down 24.2% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.48M | -24.2% |
| FY2024 | Dec 31, 2024 | $1.95M | +163.7% |
| FY2023 | Dec 31, 2023 | $741.00K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $383.00K | +1.3% |
| Q2 FY2026 | Jun 30, 2026 | $525.00K | +56.3% |
| Q1 FY2026 | Mar 31, 2026 | $424.00K | +35.9% |
| Q4 FY2025 | Dec 31, 2025 | $456.00K | +4.3% |
| Q3 FY2025 | Sep 30, 2025 | $378.00K | -56.9% |
| Q2 FY2025 | Jun 30, 2025 | $336.00K | -4.0% |
| Q1 FY2025 | Mar 31, 2025 | $312.00K | +8.0% |
| Q4 FY2024 | Dec 31, 2024 | $437.00K | +1406.9% |
| Q3 FY2024 | Sep 30, 2024 | $878.00K | +124.0% |
| Q2 FY2024 | Jun 30, 2024 | $350.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $289.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $29.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $392.00K | – |
See a number that looks wrong?